Podcasts about Smoking cessation

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-433 Overview: E-cigarette use has risen significantly, especially among adolescents and young adults. Many people begin vaping alongside conventional cigarettes in an effort to quit or reduce smoking. But risks are emerging, challenging the belief that vaping is safer than combustible cigarettes. Join us as we explore the latest evidence on vaping, dual use, and the associated health risks. Episode resource links: Hamoud J, Hanewinkel R, Andreas S, et al. A Systematic Review Investigating the Impact of Dual Use of E-Cigarettes and Conventional Cigarettes on Smoking Cessation. ERJ Open Res 2024; in press (https://doi.org/10.1183/23120541.00902-2024). Lindson N, Butler AR, McRobbie H, et al. Electronic cigarettes for smoking cessation. Cochrane Database Syst Rev. 2024;1(1):CD010216. Published 2024 Jan 8. doi:10.1002/14651858.CD010216.pub8 Pisinger C, Rasmussen SKB. The Health Effects of Real-World Dual Use of Electronic and Conventional Cigarettes versus the Health Effects of Exclusive Smoking of Conventional Cigarettes: A Systematic Review. Int J Environ Res Public Health. 2022;19(20):13687. Published 2022 Oct 21. doi:10.3390/ijerph192013687 Nabbout, M. RSNA Press Release: Vaping Causes Immediate Effects on Vascular Function.  NIH-funded studies show damaging effects of vaping, smoking on blood vessels.  Kramarow, EA & Elgaddal, MS. Current Electorinc Cigarette Use Amoing Adults Aged 19 and Over: US, 2021. NCHS Data Brief, #475, Juky 2023.  CDC/NCHS Data: https://www.cdc.gov/nchs/fastats/smoking.htm Guest: Susan Feeney, DNP, FNP-BC, NP-C   Music Credit: Matthew Bugos Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com  

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-433 Overview: E-cigarette use has risen significantly, especially among adolescents and young adults. Many people begin vaping alongside conventional cigarettes in an effort to quit or reduce smoking. But risks are emerging, challenging the belief that vaping is safer than combustible cigarettes. Join us as we explore the latest evidence on vaping, dual use, and the associated health risks. Episode resource links: Hamoud J, Hanewinkel R, Andreas S, et al. A Systematic Review Investigating the Impact of Dual Use of E-Cigarettes and Conventional Cigarettes on Smoking Cessation. ERJ Open Res 2024; in press (https://doi.org/10.1183/23120541.00902-2024). Lindson N, Butler AR, McRobbie H, et al. Electronic cigarettes for smoking cessation. Cochrane Database Syst Rev. 2024;1(1):CD010216. Published 2024 Jan 8. doi:10.1002/14651858.CD010216.pub8 Pisinger C, Rasmussen SKB. The Health Effects of Real-World Dual Use of Electronic and Conventional Cigarettes versus the Health Effects of Exclusive Smoking of Conventional Cigarettes: A Systematic Review. Int J Environ Res Public Health. 2022;19(20):13687. Published 2022 Oct 21. doi:10.3390/ijerph192013687 Nabbout, M. RSNA Press Release: Vaping Causes Immediate Effects on Vascular Function.  NIH-funded studies show damaging effects of vaping, smoking on blood vessels.  Kramarow, EA & Elgaddal, MS. Current Electorinc Cigarette Use Amoing Adults Aged 19 and Over: US, 2021. NCHS Data Brief, #475, Juky 2023.  CDC/NCHS Data: https://www.cdc.gov/nchs/fastats/smoking.htm Guest: Susan Feeney, DNP, FNP-BC, NP-C   Music Credit: Matthew Bugos Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com  

In this episode, we review the high-yield topic ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Smoking Cessation⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠from the Psychiatry section at ⁠⁠⁠⁠⁠⁠Medbullets.com⁠⁠⁠⁠⁠⁠Follow⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Medbullets⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ on social media:Facebook: www.facebook.com/medbulletsInstagram: www.instagram.com/medbulletsofficialTwitter: www.twitter.com/medbulletsLinkedin: https://www.linkedin.com/company/medbullets

The FDA issues alert regarding a compounded topical finasteride; plant-based alkaloid shows improvement for smoking cessations; potential new treatment option for GERD; and the CDC's Advisory Committee on Immunization Practices make new recommendations.

View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter's Weekly Newsletter In this “Ask Me Anything” (AMA) episode, Peter dives deep into nicotine—a topic increasingly debated both scientifically and publicly. He clarifies the critical differences between nicotine and tobacco, highlighting why nicotine alone isn't primarily responsible for smoking's severe health consequences. Peter examines the specific risks associated with nicotine use, including addiction, sleep disruption, cardiovascular concerns, and effects on mood and anxiety. He evaluates various nicotine delivery methods, from traditional cigarettes to gums, pouches, and synthetic alternatives, ranking them according to their relative safety. Additionally, Peter explores nicotine's potential positive and negative impacts on physical performance, cognitive function, fertility, and its interactions with other stimulants like caffeine. Finally, he provides practical guidance for minimizing risks with nicotine use and offers thoughtful strategies for smoking cessation and effective nicotine replacement therapies. If you're not a subscriber and are listening on a podcast player, you'll only be able to hear a preview of the AMA. If you're a subscriber, you can now listen to this full episode on your private RSS feed or our website at the AMA #70 show notes page. If you are not a subscriber, you can learn more about the subscriber benefits here. We discuss: Revisiting the previous AMA on microplastics: low-effort, high-impact changes to significantly reduce microplastic exposure [1:45]; Overview of episode topics related to nicotine [3:30]; The current landscape of nicotine research [4:45]; Addressing the common misconception that nicotine itself is the primary cause of tobacco-related health risks [6:45]; Peter's Marlboro-branded apparel is a nostalgic tribute to the Formula One era and not a sign of support for smoking [10:00]; The limitations of current research on the health risks of nicotine itself [12:15]; The most common side effects of nicotine [18:15]; The impact of nicotine on sleep [21:30]; Nicotine and mood: how nicotine can have both anxiety-inducing and calming effects based on genetics and dosage [25:00]; The addictive properties of nicotine: factors influencing addiction risk, and why certain people may struggle more than others [29:15]; The various nicotine products and nicotine delivery methods available: effects, absorption rates, and potential risks [33:45]; The relative risks of various nicotine products: how differences in nicotine concentration, absorption rates, and presence of contaminants impact their safety [37:00]; Potential cognitive benefits of nicotine: short-term benefits and impact of chronic use [44:45]; How nicotine exposure during adolescence can negatively impact brain development [47:45]; Nicotine's potential to prevent or slow neurodegenerative diseases [50:45]; Nicotine's impact on memory, learning, and attention [52:45]; The interaction between nicotine and other stimulants, particularly caffeine [55:15]; Nicotine's potential impact on physical performance [57:15]; The potential effects of nicotine on fertility, and the challenges of distinguishing the impact of nicotine itself from the effects of smoking [58:30]; Considerations for people curious about using nicotine for its cognitive benefits [1:01:30]; How to think about nicotine: weighing cognitive claims, addiction risks, and personal tolerance [1:03:15]; The prevalence of smoking, the health risks it poses, and the substantial long-term benefits of quitting [1:05:45]; Effective strategies for smoking cessation, including the use of nicotine replacement therapies [1:09:00]; The reasons behind weight gain after quitting smoking, the role of nicotine in appetite suppression, and strategies to manage weight [1:15:30]; and More. Connect With Peter on Twitter, Instagram, Facebook and YouTube

In this episode of "Ditch the Lab Coat," Dr. Mark Bonta welcomes Dr. Behnam Banihashemi, a cardiologist specializing in cardiovascular prevention, wellness, and longevity. Dr. Banihashemi discusses the concept of Medicine 2.0, which includes advancements in pharmaceuticals and interventions that have extended life expectancy in the Western world, along with a focus on improving lifestyle choices to further enhance longevity. However, he emphasizes that the real key to living a longer, healthier life lies in addressing lifestyle factors such as fitness, nutrition, sleep, and mental health.Dr. Banihashemi explains that although cardiac procedures like stents can be life-saving during heart attacks, they do not necessarily improve life expectancy for those with stable angina. Instead, lifestyle changes have a more significant impact. He highlights the influence of pharmaceutical funding on medical research and practice, leading to an emphasis on treatments rather than preventive care.The conversation also covers the limitations of the Canadian healthcare system, which does not incentivize primary prevention, and the potential benefits of certain quick fixes like metformin or supplements like protein and creatine. Dr. Banihashemi stresses that small, consistent actions, despite not being marketable, are essential for longevity and that the healthcare system often focuses more on managing diseases than preventing them. Ultimately, individuals hold the power to take charge of their health through day-by-day lifestyle decisions, adding life to their years, not just years to their lives.Get Dr. Banihashemi's 8 Steps to Conquer Chronic Pain: A Doctor's Guide to Lifelong Relief : https://www.amazon.ca/Steps-Conquer-Chronic-Pain-Lifelong/dp/0778807118 Episode Highlights:Longevity Myths Debunked: Dr. Ben sheds light on the widespread misconception that a magic pill exists for living longer. Spoiler alert: it doesn't! Discover the habits that truly make a difference in extending not only your lifespan but also your health span.Four Pillars of Health: Learn about the core areas that Dr. Ben advocates for—Fitness, Nutrition, Sleep, and Mental Health—and how these simple, intentional choices can vastly improve your quality of life.Real Talk on Medical Interventions: Are cardiac stents the ultimate fix? Dr. Ben discusses the harsh realities of current medical practices focused on quick fixes and how lifestyle changes offer more significant benefits.The Canadian Healthcare Perspective: Ever wondered how the Canadian healthcare system affects patient care? Dr. Ben gives an insider's look into the challenges doctors face and how his new venture, the Cardiac Longevity Clinic, is pioneering a shift towards proactive, personalized healthcare.00:00 - Cardiologist Ben's Holistic Heart Health06:00 - Longevity trends in the Western world.09:08 - Impact of non-chronic mortality factors.12:04 - Cardiac stents save lives in heart attacks.16:53 - Biased pharmaceutical research investments.18:49 - Cardiology's focus: Band-Aids over causes.21:13 - Research bias in health studies.27:03 - Primary prevention system failures.28:43 - The Four Pillars for Longevity.34:43 - Integrative health consultation process.37:42 - Sustainable change through consistency.40:46 - Longevity drugs: Metformin vs. Rapamycin.45:28 - Red wine popularity: Study misinterpretations.47:00 - Wine, longevity, and confounding factors.51:13 - Patient responsibility in medication adherence.53:22 - Reflecting on longevity and lifestyle.DISCLAMER >>>>>>    The Ditch Lab Coat podcast serves solely for general informational purposes and does not serve as a substitute for professional medical services such as medicine or nursing. It does not establish a doctor/patient relationship, and the use of information from the podcast or linked materials is at the user's own risk. The content does not aim to replace professional medical advice, diagnosis, or treatment, and users should promptly seek guidance from healthcare professionals for any medical conditions.   >>>>>> The expressed opinions belong solely to the hosts and guests, and they do not necessarily reflect the views or opinions of the Hospitals, Clinics, Universities, or any other organization associated with the host or guests.       Disclosures: Ditch The Lab Coat podcast is produced by (Podkind.co) and is independent of Dr. Bonta's teaching and research roles at McMaster University, Temerty Faculty of Medicine and Queens University. 

Sarah Johnston, AARC/AACVPR, is a Registered Respiratory Therapist in Riverside Medical Center's Cardiopulmonary Rehab and discusses smoking cessation and its relation to respiratory therapy.

On this West Virginia Morning, West Virginia's tobacco use and prevention efforts again earned failing grades on an assessment from the American Lung Association, and researchers look at the effects of the East Palestine derailment. The post State Scores Low On Smoking Cessation And Researching The East Palestine Derailment, This West Virginia Morning appeared first on West Virginia Public Broadcasting.

In this episode, smoking one cigarette shortens life expectancy by an average of 20 minutes, with 17 minutes for men and 22 minutes for women, as shown by data from Britain. Also in this bpodcast, brief vigorous activity, like climbing stairs or carrying groceries, can lower cardiovascular risks, with just 3.4 minutes daily reducing major events by 45%. Finally, advances in cancer prevention, screening, and treatment since 1975 have averted nearly 6 million deaths, highlighting the critical role of early detection and smoking reduction in mortality reduction.

Jo Cheah talks with Eileen Cole, GP lead, and Jennifer Kyi, pharmacist advisor at Quit, about the use of therapeutic vapes for smoking cessation. They discuss the current evidence and new Australian guidelines. The conversation also covers choosing a vape and how to prescribe or supply vapes. Read the full article by Eileen, Jennifer, and their co-authors, in Australian Prescriber.

What does the body of evidence say about smoking cessation? Does counselling make a difference and, if so, what kind? Is vaping effective as a way to quit smoking? And did you know there are drugs that have been shown to help give up the habit? Chris attempts to pronounce their names and is left with one question: is his veranda clean?   Become a supporter of our show today either on Patreon or through PayPal! Thank you! http://www.patreon.com/thebodyofevidence/ https://www.paypal.com/donate?hosted_button_id=9QZET78JZWCZE   Email us your questions at thebodyofevidence@gmail.com.   Assistant researcher: Aigul Zaripova, MD Theme music: “Fall of the Ocean Queen“ by Joseph Hackl Rod of Asclepius designed by Kamil J. Przybos Chris' book, Does Coffee Cause Cancer?: https://ecwpress.com/products/does-coffee-cause-cancer   Obviously, Chris is not your doctor (probably). This podcast is not medical advice for you; it is what we call information.   References: Reducing vs. quitting smoking 1) Gerber Y, Myers V, Goldbourt U. Smoking reduction at midlife and lifetime mortality risk in men: a prospective cohort study. Am J Epidemiol. 2012 May 15;175(10):1006-12. doi: 10.1093/aje/kwr466. Epub 2012 Feb 3. PMID: 22306566. 2) Nina S. Godtfredsen, Claus Holst, Eva Prescott, Jørgen Vestbo, Merete Osler, Smoking Reduction, Smoking Cessation, and Mortality: A 16-year Follow-up of 19,732 Men and Women from the Copenhagen Centre for Prospective Population Studies, American Journal of Epidemiology, Volume 156, Issue 11, 1 December 2002, Pages 994–1001, https://doi.org/10.1093/aje/kwf150   Behavioural interventions for smoking cessation 3) Cahill K, Lancaster T, Green N. Stage-based interventions for smoking cessation. Cochrane Database Syst Rev. 2010 Nov 10;(11):CD004492. doi: 10.1002/14651858.CD004492.pub4. PMID: 21069681. 4) Stead LF, Koilpillai P, Fanshawe TR, Lancaster T. Combined pharmacotherapy and behavioural interventions for smoking cessation. Cochrane Database Syst Rev. 2016 Mar 24;3(3):CD008286. doi: 10.1002/14651858.CD008286.pub3. PMID: 27009521; PMCID: PMC10042551. 5) Hartmann-Boyce J, Hong B, Livingstone-Banks J, Wheat H, Fanshawe TR. Additional behavioural support as an adjunct to pharmacotherapy for smoking cessation. Cochrane Database Syst Rev. 2019 Jun 5;6(6):CD009670. doi: 10.1002/14651858.CD009670.pub4. PMID: 31166007; PMCID: PMC6549450. 6) Hartmann-Boyce J, Livingstone-Banks J, Ordóñez-Mena JM, Fanshawe TR, Lindson N, Freeman SC, Sutton AJ, Theodoulou A, Aveyard P. Behavioural interventions for smoking cessation: an overview and network meta-analysis. Cochrane Database Syst Rev. 2021 Jan 4;1(1):CD013229. doi: 10.1002/14651858.CD013229.pub2. PMID: 33411338; PMCID: PMC11354481. 7) Anthenelli RM, Benowitz NL, West R, St Aubin L, McRae T, Lawrence D, Ascher J, Russ C, Krishen A, Evins AE. Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial. Lancet. 2016 Jun 18;387(10037):2507-20. doi: 10.1016/S0140-6736(16)30272-0. Epub 2016 Apr 22. PMID: 27116918.   Network meta-analysis of medications and e-cigarettes 8) Lindson N, Theodoulou A, Ordóñez-Mena JM, Fanshawe TR, Sutton AJ, Livingstone-Banks J, Hajizadeh A, Zhu S, Aveyard P, Freeman SC, Agrawal S, Hartmann-Boyce J. Pharmacological and electronic cigarette interventions for smoking cessation in adults: component network meta‐analyses. Cochrane Database of Systematic Reviews 2023, Issue 9. Art. No.: CD015226. DOI: 10.1002/14651858.CD015226.pub2. Accessed 04 November 2024.  

In this episode of the St. Emlyn's podcast, hosts Iain Beardsell and Simon Carley share their insights from recent conferences, including Gateshead's RCEM scientific conference, Tactical Trauma 24 in Sweden, and the Premier Conference. They explore 'Goldilocks moments' for executing life-saving procedures in critical care, emphasizing optimal timing for interventions like thoracotomies. The episode also discusses innovative training methods like shadowboxing to enhance decision-making in high-stress medical scenarios. In addition, they review a significant trial on smoking cessation in emergency departments, highlighting its potential role in broader public health initiatives, including sexual health and HIV screening. Discussions also cover various pain management strategies, such as the use of intranasal vs. intravenous Ketorolac for renal colic. The hosts critique the traditional peer review process in medical research and advocate for open peer review to support equitable and accessible scientific publishing. 00:00 Introduction and Catching Up 02:07 The Goldilocks Moment in Critical Care 05:25 Training and Decision-Making in Emergency Procedures 07:23 Smoking Cessation in Emergency Departments 10:07 Challenges in Implementing Preventive Health Strategies 10:38 Successful Public Health Projects in Emergency Medicine 11:19 Exploring Alternative Interventions in Emergency Departments 11:52 Highlights from the Premier Conference 12:54 Intranasal Ketorolac for Pain Management 15:46 The Future of Peer Review in Medical Research 20:09 Concluding Thoughts and Upcoming Content

It is still difficult for patients to quit despite their best efforts. Of the nearly 70% of current smokers who want to quit smoking, only about 7.5% succeed.  Unfortunately, there is a lack of evidence to inform subsequent treatment strategies if the initial quit attempt is unsuccessful. Guest Authors:  Elizabeth Yett, PharmD, BCACP, TTS and Katherine Montag Schafer, PharmD, BCACP, CDCES Music by Good Talk

DISCLAMER >>>>>>    The Ditch Lab Coat podcast serves solely for general informational purposes and does not serve as a substitute for professional medical services such as medicine or nursing. It does not establish a doctor/patient relationship, and the use of information from the podcast or linked materials is at the user's own risk. The content does not aim to replace professional medical advice, diagnosis, or treatment, and users should promptly seek guidance from healthcare professionals for any medical conditions.   >>>>>> The expressed opinions belong solely to the hosts and guests, and they do not necessarily reflect the views or opinions of the Hospitals, Clinics, Universities, or any other organization associated with the host or guests.       Disclosures: Ditch The Lab Coat podcast is produced by (Podkind.co) and is independent of Dr. Bonta's teaching and research roles at McMaster University, Temerty Faculty of Medicine and Queens University. Welcome to "Ditch the Lab Coat," the podcast where we dive into pressing health issues with scientific skepticism and heartfelt curiosity. I'm your host, Dr. Mark Bonta, and in this episode we have a special guest, Dr. Spencer Nadolsky. Dr. Nadolsky is a board-certified obesity and lipid specialist known for his straightforward approach to fitness and health, and for pioneering obesity management via telemedicine. In this episode, we'll dive into various topics, including the intricacies of Lipoprotein(a) and its impact on cardiovascular health, the balance between lifestyle changes and pharmaceutical interventions, and the challenges of research funding in lifestyle modifications. We'll also explore Spencer's insights on effective weight loss strategies, sustainable diets, and his personal journey with health and fitness. So, whether you're here to glean some practical tips or to understand the latest in medical research, stay tuned—this is going to be an enlightening conversation.04:44 Sustainable weight loss requires satiating, nutritious food.08:55 Intermittent fasting, increased exercise caused weight loss.10:57 Dietary composition impacts health beyond weight loss.14:05 Appetite largely dictates body weight and thinness.17:09 Medication and bariatric surgery enhance weight loss results.20:55 Future obesity prevention: targeting genetic and socioeconomic risks.22:47 Medications reduce hypertension but overlook underlying causes.25:51 Drug trial: ~10% weight loss, possible cardiovascular benefits.29:32 Higher LDL and APOB increase long-term plaque risk.33:40 Advise family about LDL cholesterol management realistically.38:48 High school glucose test fueled sports nutrition interest.39:59 Anti-aging field's evolving, medication secondary uses explored.45:28 Biopsychosocial model emphasizes controllable and uncontrollable factors.47:31 Lifestyle changes are equally important as medications.49:49 Exciting times ahead; feedback appreciated. Stay tuned.

Doctors Lisa and Sara talk to Respiratory Physiotherapist Thomas James about COPD. We start with what COPD is, when to suspect it, a standard work up, pitfalls and points of consideration about spirometry, before moving on to an overview of management. We then cover some changes in the way COPD exacerbations are managed in South Manchester and the role of Eosinophils in both acute and chronic management. Understanding the role of Pulmonary rehabilitation, prednisolone and exercise in management are particular highlights. We cover our learning points from the episode at the end.  You can use these podcasts as part of your CPD - we don't do certificates but they still count :) Useful resources:  NICE COPD in adults (last updated Sept 2023): https://www.nice.org.uk/guidance/QS10 The Global Initiative for Chronic Obstructive Lung Disease (GOLD) Spirometry Guide: https://goldcopd.org/gold-spirometry-guide/ Association for Respiratory Technology and Physiology (ARTP) advice on Spirometry Interpretation: https://www.artp.org.uk/en/spirometry Greater Manchester Medicines Management Group (GMMMG) COPD Management Plan Guideline (2021): https://gmmmg.nhs.uk/wp-content/uploads/2021/11/COPD-Treatment-Guideline-Nov-2021-V7.1.pdf Greater Manchester Medicines Management Group (GMMMG) COPD Inhaler Guide (2021): https://gmmmg.nhs.uk/wp-content/uploads/2023/05/GMMMG-COPD-Inhaler-Guide-update-Mar-2023.pdf Greater Manchester CURE Project for Smoking Cessation: https://gmcancer.org.uk/programmes-of-work/treatment/the-cure-project/ Greater Manchester Change, Grow, Live Services including Smoking Cessation: https://www.changegrowlive.org/ Primary Care Respiratory Society MRC Breathlessness scale: https://www.pcrs-uk.org/mrc-dyspnoea-scale Our podcast with Dr Lesley Henson and Dr Caitriona MacDermott on Breathlessness in Palliative Care (May 2024): https://pckb.org/e/breathlessness-in-palliative-care/ ___ We really want to make these episodes relevant and helpful: if you have any questions or want any particular areas covered then contact us on Twitter @PCKBpodcast, or leave a comment on our quick anonymous survey here: https://pckb.org/feedback Email us at: primarycarepodcasts@gmail.com ___ This podcast has been made with the support of GP Excellence and Greater Manchester Integrated Care Board. Given that it is recorded with Greater Manchester clinicians, the information discussed may not be applicable elsewhere and it is important to consult local guidelines before making any treatment decisions.  The information presented is the personal opinion of the healthcare professional interviewed and might not be representative to all clinicians. It is based on their interpretation of current best practice and guidelines when the episode was recorded. Guidelines can change; To the best of our knowledge the information in this episode is up to date as of it's release but it is the listeners responsibility to review the information and make sure it is still up to date when they listen. Dr Lisa Adams, Dr Sara MacDermott and their interviewees are not liable for any advice, investigations, course of treatment, diagnosis or any other information, services or products listeners might pursue as a result of listening to this podcast - it is the clinicians responsibility to appraise the information given and review local and national guidelines before making treatment decisions. Reliance on information provided in this podcast is solely at the listeners risk. The podcast is designed to be used by trained healthcare professionals for education only. We do not recommend these for patients or the general public and they are not to be used as a method of diagnosis, opinion, treatment or medical advice for the general public. Do not delay seeking medical advice based on the information contained in this podcast. If you have questions regarding your health or feel you may have a medical condition then promptly seek the opinion of a trained healthcare professional.

DISCLAMER >>>>>>    The Ditch Lab Coat podcast serves solely for general informational purposes and does not serve as a substitute for professional medical services such as medicine or nursing. It does not establish a doctor/patient relationship, and the use of information from the podcast or linked materials is at the user's own risk. The content does not aim to replace professional medical advice, diagnosis, or treatment, and users should promptly seek guidance from healthcare professionals for any medical conditions.   >>>>>> The expressed opinions belong solely to the hosts and guests, and they do not necessarily reflect the views or opinions of the Hospitals, Clinics, Universities, or any other organization associated with the host or guests.       Disclosures: Ditch The Lab Coat podcast is produced by (Podkind.co) and is independent of Dr. Bonta's teaching and research roles at McMaster University, Temerty Faculty of Medicine and Queens University. Welcome to "Ditch the Lab Coat," the podcast where we dive into pressing health issues with scientific skepticism and heartfelt curiosity. I'm your host, Dr. Mark Bonta, and in this episode, we are back with our second part to the two-part series focused on the intricate world of addiction treatment.Joining us today are two distinguished guests: Dr. Jon Mong, a general internal medicine and addictions physician, and Dr. Wiplove Lamba, an addiction psychiatrist. Together, Dr. Mong and Dr. Lamba will shed light on the promise and perils of new treatment approaches, underscore the necessity of comprehensive support systems, and point to the pivotal role of social supports and stable housing in fostering sustainable recovery.We also tackle the cultural and historical context of the opioid crisis, including the profound impact of Purdue Pharma and the Sackler family. Dispelling misconceptions about fentanyl, you'll learn about the real risks, the invaluable role of naloxone, and practical steps for overdose prevention.This episode is not just about groundbreaking therapies; we will discuss the critical need for rigorous, high-quality data to back new treatments and reflect on the significant influence of private companies in the field. Our guests will emphasize the paramount importance of addressing the root causes of substance use, building life skills, and creating supportive networks to prevent relapses.Lastly, this episode will feature discussions on opioid tolerance, withdrawal management, and the nuanced balance between the risks of prescribing medications versus the risks of untreated withdrawal. You'll gain insights into how healthcare teams can shift their perceptions and practices to better support patients with substance use disordersStay tuned as we unravel these topics and much more. So, grab your headphones and get ready for an enlightening conversation on addiction treatment with Dr. Jon Mong and Dr. Wiplove Lamba. Let's dive in!04:17 Challenges and future of addiction treatment discussed.09:36 Understanding withdrawal challenges in hospitals with unknown dosages.12:02 Provide proper care despite addiction-related complications.16:20 Colleague's guarded due to personal trauma, concerns.20:05 Conversations led hospital to adopt PICC lines.21:54 New grads integrate social responsibility with medical care.27:20 Risk from checking on overdose is minimal.29:15 There can't be too much widely accessible Narcan.34:00 Need rigorous study for psychedelics in treatment.35:39 Concerned new treatments overshadow foundational patient support measures.41:40 "Cured" involves functional life, stability, coping mechanisms.42:52 Substance use disorder: Patients can achieve long-term remission.46:01 Meet needs without substances to avoid relapse.

DISCLAMER >>>>>>    The Ditch Lab Coat podcast serves solely for general informational purposes and does not serve as a substitute for professional medical services such as medicine or nursing. It does not establish a doctor/patient relationship, and the use of information from the podcast or linked materials is at the user's own risk. The content does not aim to replace professional medical advice, diagnosis, or treatment, and users should promptly seek guidance from healthcare professionals for any medical conditions.   >>>>>> The expressed opinions belong solely to the hosts and guests, and they do not necessarily reflect the views or opinions of the Hospitals, Clinics, Universities, or any other organization associated with the host or guests.       Disclosures: Ditch The Lab Coat podcast is produced by (Podkind.co) and is independent of Dr. Bonta's teaching and research roles at McMaster University, Temerty Faculty of Medicine and Queens University. Welcome to "Ditch the Lab Coat," the podcast where we dive into pressing health issues with scientific skepticism and heartfelt curiosity. I'm your host, Dr. Mark Bonta, and in this episode, we're embarking on the first of a two-part series focused on the intricate world of addiction treatment.Joining us today are two distinguished guests: Dr. Jon Mong, a general internal medicine and addictions physician, and Dr. Wiplove Lamba, an addiction psychiatrist. Together, we'll explore the complexities of managing and treating addiction within hospital settings, the profound challenges faced by patients and healthcare providers alike, and the life-saving implications of treatments like opioid agonist therapy.In this episode, we tackle the high relapse rates among opiate users, the effectiveness of medications for alcohol use disorders, and the importance of patient readiness in overcoming substance use. We'll also delve into the value of motivational interviewing in fostering patient cooperation and the evolving role of addiction medicine in modern healthcare.Dr. Bonta reflects on his experiences and frustrations with addiction treatment, emphasizing the need for evidence-based approaches and reducing harm. We'll discuss the broader implications of addiction treatments, including societal perceptions and the importance of treating addiction as a complex, multifaceted issue.Stay tuned as we unravel these topics and much more. So, grab your headphones and get ready for an enlightening conversation on addiction treatment with Dr. Jon Mong and Dr. Wiplove Lamba. Let's dive in!06:28 Biopsychosocial overview and social determinants of health.08:33 Addiction perception varies; harm reduction prioritizes context.12:42 Substance use disorder defined by the four C's.15:24 Challenges of informing patients about health impacts succinctly.20:11 Enjoyed working with you; motivational interviewing technique.21:40 Promote cooperation and autonomy in medical interactions.24:38 Brief interventions reveal deeper patient issues for treatment.30:23 Support for treating illness without moral judgment.31:43 Understanding treatments can improve patient prognosis discussions.34:59 Medication modulates neurotransmitters for alcohol use disorder.39:44 Four reasons to start opioid agonist therapy.42:14 Discharged patients risk fatal overdose; opioid therapy saves.46:42 Patients generally agree with treatment but resist lifestyle changes.49:00 Importance of discussing addiction and enabling behaviors.

In episode 46 we discuss using high doses of varenicline and nicotine for smoking cessation.    Cinciripini PM, Green CE, Shete S, Minnix JA, Robinson JD, Cui Y, Kim S, Kypriotakis G, Beneventi D, Blalock JA, Versace F, Karam-Hage M. Smoking Cessation After Initial Treatment Failure With Varenicline or Nicotine Replacement: A Randomized Clinical Trial. JAMA. 2024 May 28; 331(20):1722-1731.    We also discuss resources for safer substance use, and the recall of dangerous Diamond Shrooms.    Yale Program in Addiction Medicine: Resources for Safer Injection and Substance Use    San Francisco Aids Foundation: Safer Drug Use    CDC: Severe Illness Potentially Associated with Consuming Diamond ShruumzTM Brand Chocolate Bars, Cones, and Gummies  ---  This podcast offers category 1 and MATE-ACT CME credits through MI CARES and Michigan State University. To get credit for this episode and others, go to this link to make your account, take a brief quiz, and claim your credit. To learn more about opportunities in addiction medicine, visit MI CARES.  CME: https://micaresed.org/courses/podcast-addiction-medicine-journal-club/ ---  Original theme music: composed and performed by Benjamin Kennedy  Audio Editing by Michael Bonanno Executive Producer: Dr. Patrick Beeman  A podcast from Ars Longa Media  ---  This is Addiction Medicine Journal Club with Dr. Sonya Del Tredici and Dr. John Keenan. We practice addiction medicine and primary care, and we believe that addiction is a disease that can be treated. This podcast reviews current articles to help you stay up to date with research that you can use in your addiction medicine practice.    The best part of any journal club is the conversation. Send us your comments on social media or join our Facebook group.    Email: addictionmedicinejournalclub@gmail.com  Facebook: @AddictionMedJC  Facebook Group: Addiction Medicine Journal Club  Instagram: @AddictionMedJC  Threads: @AddictionMedJC  YouTube: addictionmedicinejournalclub  Twitter/X: @AddictionMedJC     Addiction Medicine Journal Club is intended for educational purposes only and should not be considered medical advice. The views expressed here are our own and do not necessarily reflect those of our employers or the authors of the articles we review. All patient information has been modified to protect their identities. 

Rob Schutz is the co-founder of the unicorn Ro, a healthcare company that initially offered ED medications and later expanded into other products and services for sexual health, weight loss, fertility, hair, and skin. Prior to Ro, Rob was instrumental in the exponential growth of BARK/BarkBox, a now prominent subscription service for dog products. Currently, at Snagged.com, he is focused on helping businesses acquire premium domain names and digital assets.In this episode of the DTC POD, Rob shares valuable insights into the growth strategies that have contributed to the success of both BARK/BarkBox and Ro. He discusses the importance of focusing on core, consistent marketing channels such as paid search, paid social, and email, while also allocating a separate budget for testing and exploring new, experimental strategies and channels.Rob offers practical advice for founders and marketers, stressing the need to plan for scale, set and clearly communicate priorities, foster strong relationships between growth and marketing leaders, and structure teams effectively as the company experiences rapid growth. He also shares his expertise in domain brokerage, discussing strategies for acquiring and negotiating domain names to help build strong brand identities.Interact with other DTC experts and access our monthly fireside chats with industry leaders on DTC Pod Slack.On this episode of DTC Pod, we cover:1. DTC Marketing Strategies2. Optimizing Marketing Budget3. Testing Marketing Channels4. Digital Marketing Challenges5. Building and Structuring Teams6. Importance of Domain NamesTimestamps00:00 Rob Schutz's DTC experience: BARK/BarkBox, Ro, Snagged.com07:37 Process of acquiring domain names11:10 Why Rob Schutz founded Snagged.com14:28 From User Acquisition Manager to VP of Growth at BARK/BarkBox16:27 Lessons from BARK/BarkBox's growth journey20:56 Strategies for choosing and testing growth channels26:09 Transitioning from BARK/BarkBox to Ro29:00 Challenge with digital performance platforms in the early days of Ro31:33 Rolling out Ro's ED medication state-by-state, launching other products35:47 Planning for scale around high quality of care35:51 Iterations around how to structure the team as Ro scaled41:47 Rob Schutz's advice to founders46:35 Sports sponsorship as a performance channel48:10 Snagged.com's domain servicesShow notes powered by CastmagicPast guests & brands on DTC Pod include Gilt, PopSugar, Glossier, MadeIN, Prose, Bala, P.volve, Ritual, Bite, Oura, Levels, General Mills, Mid Day Squares, Prose, Arrae, Olipop, Ghia, Rosaluna, Form, Uncle Studios & many more.  Additional episodes you might like:• #175 Ariel Vaisbort - How OLIPOP Runs Influencer, Community, & Affiliate Growth• #184 Jake Karls, Midday Squares - Turning Your Brand Into The Influencer With Content• #205 Kasey Stewart: Suckerz- - Powering Your Launch With 300 Million Organic Views• #219 JT Barnett: The TikTok Masterclass For Brands• #223 Lauren Kleinman: The PR & Affiliate Marketing Playbook• ​​​​#243 Kian Golzari - Source & Develop Products Like The World's Best Brands-----Have any questions about the show or topics you'd like us to explore further?Shoot us a DM; we'd love to hear from you.Want the weekly TL;DR of tips delivered to your mailbox?Check out our newsletter here.Projects the DTC Pod team is working on:DTCetc - all our favorite brands on the internetOlivea - the extra virgin olive oil & hydroxytyrosol supplementCastmagic - AI Workspace for ContentFollow us for content, clips, giveaways, & updates!DTCPod InstagramDTCPod TwitterDTCPod TikTok  Rob Schutz - Co-Founder of Ro and Founder of Snagged.comBlaine Bolus - Co-Founder of CastmagicRamon Berrios - Co-Founder of Castmagic

I invite you to find out more about the 4-Week Hypnosis Coaching Program for Smoking Cessation: https://quitsmokingtodaypodcast.com/hypnosis You might also want to find out more about this supplement that was specifically created to support healthy lungs and a healthy respiratory system: https://quitsmokingtodaypodcast.com/breathe (This is an affiliate link. If you click through and make a purchase, I'll earn a commission, at no additional cost to you)

We all struggle counseling patients on smoking cessation. Today, expert and director of the Mayo Clinic Nicotine Dependence Center joins us to share his career journey and give us some fascinating data and tips of how to get your patients to quit smoking for good. Subscribe to the podcast:  https://MayoClinicOphthalmology.podbean.com   Follow and reach out to us on X and Instagram: @mayocliniceye 

Fresh episode from #MEMA24 in Harbor Springs, MI, talking with Dr. Henry Moss, discussing whippit abuse and smoking cessation. Two topics, one podcast!

I invite you to find out more about the 4-Week Hypnosis Coaching Program for Smoking Cessation: https://quitsmokingtodaypodcast.com/hypnosis You might also want to find out more about this very affordable supplement that was specifically created to support healthy lungs and a healthy respiratory system: https://quitsmokingtodaypodcast.com/breathe (This is an affiliate link. If you click through and make a purchase, I'll earn a commission, at no additional cost to you)  

I invite you to find out more about the 4-Week Hypnosis Coaching Program for Smoking Cessation: https://quitsmokingtodaypodcast.com/hypnosis You might also want to find out more about this very affordable supplement that was specifically created to support healthy lungs and a healthy respiratory system: https://quitsmokingtodaypodcast.com/breathe (This is an affiliate link. If you click through and make a purchase, I'll earn a commission, at no additional cost to you)

I invite you to find out more about the 4-Week Hypnosis Coaching Program for Smoking Cessation: https://quitsmokingtodaypodcast.com/hypnosis You might also want to find out more about this very affordable supplement that was specifically created to support healthy lungs and a healthy respiratory system: https://quitsmokingtodaypodcast.com/breathe (This is an affiliate link. If you click through and make a purchase, I'll earn a commission, at no additional cost to you)

I invite you to find out more about the 4-Week Hypnosis Coaching Program for Smoking Cessation: https://quitsmokingtodaypodcast.com/hypnosis You might also want to find out more about this very affordable supplement that was specifically created to support healthy lungs and a healthy respiratory system: https://quitsmokingtodaypodcast.com/breathe (This is an affiliate link. If you click through and make a purchase, I'll earn a commission, at no additional cost to you)

I invite you to find out more about the 4-Week Hypnosis Coaching Program for Smoking Cessation: https://quitsmokingtodaypodcast.com/hypnosis You might also want to find out more about this very affordable supplement that was specifically created to support healthy lungs and a healthy respiratory system: https://quitsmokingtodaypodcast.com/breathe (This is an affiliate link. If you click through and make a purchase, I'll earn a commission, at no additional cost to you)

I invite you to find out more about my 4-Week Hypnosis Coaching Program for Smoking Cessation: https://www.quitsmokingtodaypodcast.com/hypnosis 

Lung cancer care begins with prevention. This podcast aims to provide expert insights and practical advice on quitting smoking. We explore the opt-out approach, an effective strategy for initiating conversations about quitting smoking, and provide a comprehensive overview of pharmacotherapy options available to support the patients through their smoking cessation journey. Tune in as we tackle common questions and concerns faced by patients, offering practical tips and guidance to help you kick the habit for good. Disclosures: no financial interests in the production of this material

I invite you to find out more about the 4-Week Hypnosis Coaching Program for Smoking-Cessation that has helped people from all over the world to break free from their addiction to cigarettes: https://www.quitsmokingtodaypodcast.com 

I invite you to find out more about the 4-Week Hypnosis Coaching Program for Smoking-Cessation that has helped people from all over the world to break free from their addiction to cigarettes: https://www.quitsmokingtodaypodcast.com 

I invite you to find out more about the 4-Week Hypnosis Coaching Program for Smoking-Cessation that has helped people from all over the world to break free from their addiction to cigarettes: https://www.quitsmokingtodaypodcast.com 

I invite you to find out more about the 4-Week Hypnosis Coaching Program for Smoking-Cessation that has helped people from all over the world to break free from their addiction to cigarettes: https://www.quitsmokingtodaypodcast.com 

I invite you to find out more about the 4-Week Hypnosis Coaching Program for Smoking-Cessation that has helped people from all over the world to break free from their addiction to cigarettes: https://www.quitsmokingtodaypodcast.com 

What are the current smoking rates among LGBTQIA+ individuals compared to the general population? What unique barriers do LGBTQIA+ individuals face when trying to quit smoking? What are the recommended pharmacotherapies and behavioral interventions for smoking cessation? What training is needed for providers to deliver culturally affirmative smoking cessation treatment for LGBTQIA+ patients?  Dr. Rhonda Schwindt is an Associate Professor at The George Washington University School of Nursing. She is a nationally certified Psychiatric-Mental Health Nurse Practitioner with an active clinical practice specializing in LGBTQIA+ health, trauma, and treatment-resistant mood disorders. Dr. Schwindt earned a Doctor of Nursing Practice degree from Case Western Reserve University, a Master of Science in Nursing from Indiana University School of Nursing, a Bachelor of Arts from Purdue University, and a diploma in nursing from St. Elizabeth School of Nursing. Dr. Schwindt has a funded program of research focused on improving health outcomes for the LGBTQIA+ community. She led a team of researchers that examined barriers to, and facilitators of, smoking cessation and treatment utilization in the transgender and gender expansive population as well as studies exploring best practices for teaching graduate students how to provide affirming care. Dr. Schwindt has received international recognition as an outstanding graduate nurse educator and for clinical excellence in the care of persons living with serious mental illness.  Resources  Pride in Being Tobacco-Free  UCSF Smoking Cessation Leadership Center  Fenway Health  Trevor Project 

I invite you to find out more about the 4-Week Hypnosis Coaching Program for Smoking-Cessation that has helped people from all over the world to break free from their addiction to cigarettes: https://www.quitsmokingtodaypodcast.com 

I invite you to find out more about the 4-Week Hypnosis Coaching Program for Smoking-Cessation that has helped people from all over the world to break free from their addiction to cigarettes: https://www.quitsmokingtodaypodcast.com 

I invite you to find out more about the 4-Week Hypnosis Coaching Program for Smoking-Cessation that has helped people from all over the world to break free from their addiction to cigarettes: https://www.quitsmokingtodaypodcast.com 

I invite you to find out more about the 4-Week Hypnosis Coaching Program for Smoking-Cessation that has helped people from all over the world to break free from their addiction to cigarettes: https://www.quitsmokingtodaypodcast.com 

In this episode, we dive into the complex narrative of electronic cigarettes and their role in smoking cessation. Join Josh and Adam as they review research showing e-cigarettes as safer than traditional cigarettes in terms of chemical exposure while also examining the risks for non-smokers.We present evidence that nicotine e-cigarettes may outperform traditional nicotine replacement therapies like patches and gums. Supported by sources such as the American Journal of Public Health and Cochrane, we compare e-cigarettes with Chantix (varenicline) for smoking cessation. We highlight clinical outcomes and the under-researched long-term side effects of e-cigarettes.Engage with us on social media and share your thoughts and suggestions for future episodes. Thank you for joining the Doctor Journal Club podcast!Learn more and become a member at www.DrJournalClub.comCheck out our complete offerings of NANCEAC-approved Continuing Education Courses.

I invite you to find out more about the 4-Week Hypnosis Coaching Program for Smoking-Cessation that has helped people from all over the world to break free from their addiction to cigarettes: https://www.quitsmokingtodaypodcast.com 

I invite you to find out more about the 4-Week Hypnosis Coaching Program for Smoking-Cessation that has helped people from all over the world to break free from their addiction to cigarettes: https://www.quitsmokingtodaypodcast.com 

Hypnotherapy is now recognized as a credible alternative treatment for many mental health related disorders including addiction, anxiety, and depression. Sheila Webber, a skilled hypnotherapist, talks with Beyond Well about how hypnotherapy works, the therapeutic benefits of a hypnotic state, and how to find a skilled practitioner. You can learn more about Sheila's practice at https://shifthypnosis.org/

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-381 Overview: While the aerosol in e-cigarettes does contain toxicants and carcinogens, since it is not burned like combustible tobacco cigarettes, vaping exposes the user to fewer toxicants and chemicals. Many consider using e-cigarettes for smoking cessation, but evidence has been conflicting. Tune in as we discuss a recent review examining the efficacy of e-cigarettes in aiding smoking cessation and explore potential adverse effects associated with their usage. Episode resource links: Lin, H. X., Liu, Z., Hajek, P., Zhang, W. T., Wu, Y., Zhu, B. C., Liu, H. H., Xiang, Q., Zhang, Y., Li, S. B., Pesola, F., & Wang, Y. Y. (2024). Efficacy of Electronic Cigarettes vs Varenicline and Nicotine Chewing Gum as an Aid to Stop Smoking: A Randomized Clinical Trial. JAMA internal medicine, 10.1001/jamainternmed.2023.7846. Advance online publication. https://doi.org/10.1001/jamainternmed.2023.7846 Lindson, N., Butler, A. R., McRobbie, H., Bullen, C., Hajek, P., Begh, R., Theodoulou, A., Notley, C., Rigotti, N. A., Turner, T., Livingstone-Banks, J., Morris, T., & Hartmann-Boyce, J. (2024). Electronic cigarettes for smoking cessation. The Cochrane database of systematic reviews, 1(1), CD010216. https://doi.org/10.1002/14651858.CD010216.pub8 Sanford BT, Brownstein NC, Baker NL, et al. Shift From Smoking Cigarettes to Vaping Nicotine in Young Adults. JAMA Intern Med. Published online November 13, 2023. doi:10.1001/jamainternmed.2023.5239 Guest: Susan Feeney, DNP, FNP-BC, NP-C   Music Credit: Richard Onorato

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-381 Overview: While the aerosol in e-cigarettes does contain toxicants and carcinogens, since it is not burned like combustible tobacco cigarettes, vaping exposes the user to fewer toxicants and chemicals. Many consider using e-cigarettes for smoking cessation, but evidence has been conflicting. Tune in as we discuss a recent review examining the efficacy of e-cigarettes in aiding smoking cessation and explore potential adverse effects associated with their usage. Episode resource links: Lin, H. X., Liu, Z., Hajek, P., Zhang, W. T., Wu, Y., Zhu, B. C., Liu, H. H., Xiang, Q., Zhang, Y., Li, S. B., Pesola, F., & Wang, Y. Y. (2024). Efficacy of Electronic Cigarettes vs Varenicline and Nicotine Chewing Gum as an Aid to Stop Smoking: A Randomized Clinical Trial. JAMA internal medicine, 10.1001/jamainternmed.2023.7846. Advance online publication. https://doi.org/10.1001/jamainternmed.2023.7846 Lindson, N., Butler, A. R., McRobbie, H., Bullen, C., Hajek, P., Begh, R., Theodoulou, A., Notley, C., Rigotti, N. A., Turner, T., Livingstone-Banks, J., Morris, T., & Hartmann-Boyce, J. (2024). Electronic cigarettes for smoking cessation. The Cochrane database of systematic reviews, 1(1), CD010216. https://doi.org/10.1002/14651858.CD010216.pub8 Sanford BT, Brownstein NC, Baker NL, et al. Shift From Smoking Cigarettes to Vaping Nicotine in Young Adults. JAMA Intern Med. Published online November 13, 2023. doi:10.1001/jamainternmed.2023.5239 Guest: Susan Feeney, DNP, FNP-BC, NP-C   Music Credit: Richard Onorato

When initial treatment with varenicline or nicotine replacement doesn't work, does increasing dosage improve smoking cessation rates? Paul Cinciripini, PhD, of MD Anderson Cancer Center's Department of Behavioral Science, joins JAMA Executive Editor Gregory Curfman, MD, to discuss guidance on the best strategies for smoking cessation following an initial quit attempt. Related Content: Smoking Cessation After Initial Treatment Failure With Varenicline or Nicotine Replacement

Which supplements should be taken by themselves without food, and which to take in the AM and PM? Pros/cons of hormone replacement therapy for menopause; Natural treatment of rheumatoid arthritis; Covid after non-Hodgkin's disease—is there a concern? Vitamin D scores vs. hard-to-treat cancers; A shocking approach to smoking cessation; 10 reasons why seniors go to ground.

Adam creates a hypnosis session to help a client solidify their new identity as a non-smoker. Adam uses regression to reframe how they started smoking and gives positive suggestions about what a future of being a non-smoker would mean for their life, freedom and future.  FREE HYPNOSIS DOWNLOADS: To thank you for being a listener to the show Adam is giving you 100% FREE hypnosis downloads worth up to £130/$150 using the coupon code FREE here: https://www.adamcox.co.uk/store/c15/FREE-Hypnosis  There is a 50% Discount on up to 10 other downloads using the coupon code hypnotist here: https://www.adamcox.co.uk/downloads.html  And finally, if you want to work with Adam on a one-to-one basis on hypnosis sessions, wealth coaching, or mentorship you can book sessions here: https://www.adamcox.co.uk/hypnotherapist.html  ABOUT ADAM Adam Cox is one of the world's most innovative hypnotists and is known for being the hypnotherapist of choice for Celebrities, CEO's and even Royalty. To book a free 30-minute consultation call to consider working with Adam go to: https://go.oncehub.com/AdamCox Adam's rates for hypnotherapy in pounds and US dollars are here: https://www.adamcox.co.uk/hypnotherapist.html  You can contact Adam at adam@adamcox.co.uk Further information on Adam is here: https://linktr.ee/AdamCoxOfficial  Tags: Adam Cox, the hypnotist, NLP, asmr, hypnosis, hypnotherapy, hypnotist, stress, sleep, worry, meditation, guided meditation, hypnotism, anxiety, parts therapy, motivation, smoking, quit smoking, stop smoking, hypnosis to quit smoking, 

Join us as we review recent practice-changing articles on E-cigarettes for smoking cessation, Gabapentin and COPD exacerbations, lidocaine patches for mechanical neck pain, Cdiff risk by antibiotic type, and “dosing by clicks” for GLP1 agonists. Fill your brain hole with a delicious stack of hotcakes! Featuring Paul Williams (@PaulNWilliamz), Rahul Ganatra (@rbganatra), and Matt Watto (@doctorwatto). Claim CME for this episode at curbsiders.vcuhealth.org! Episodes | Subscribe | Spotify | Swag! |Mailing List | Contact | CME! Credits Written and Hosted by: Rahul Ganatra MD, MPH; Paul Williams, MD, FACP, Matthew Watto MD, FACP Cover Art: Matthew Watto MD, FACP Reviewer: Rahul Ganatra MD, MPH Technical Production: Pod Paste Showrunners: Matthew Watto MD, FACP; Paul Williams MD, FACP Show Segments Introduction and disclaimer E-cigarettes for smoking cessation Gabapentinoids and COPD exacerbations Topical lidocaine for neck pain Association between specific antibiotics and C. diff infection Shortage of GLP-1 agonists and “dosing by clicks” Sponsor: Locumstory Tune in to The Locumstory Podcast on Spotify, Apple, or Google podcasts. Sponsor: Freed  You can try Freed for free right now by going to freed.ai. And listeners of Curbsiders can use code CURB50 for $50 off their first month. 

Episode #297. Think hypnosis is for stage shows and witches? Think again. Learn from Stanford Professor David Spiegel about how this revolutionary treatment approach can help break bad habits, manage pain, and improve a range of conditions from insomnia to IBS. You'll learn what clinical hypnosis is, how it works, and how it differs from meditation. Dr Spiegel also addresses some common fears and misconceptions about this practice, explaining the research and how it fits in with psychotherapy and clinical guidelines. Tune in to discover whether hypnosis might be a good approach for you and how to get started. Specifically, we discuss: Intro to Hypnosis with Stanford's David Spiegel (00:00) Exploring Hypnosis with Stanford Professor David Spiegel (01:53) The Science of Hypnosis Demystified (09:12) Examples of Hypnosis in Smoking Cessation (13:17) Clinical Hypnosis: Control and Perspective Shift (18:10) Pain Management Through Hypnosis (21:46) Hypnosis in Treating PTSD and IBS (30:33) Role of Hypnosis in Psychiatry and Scientific Research (36:44) Are You Hypnotizable? (43:31) Hypnosis and Meditation: Understanding the Differences (48:27) Efficacy of Hypnosis via Apps: Usage and Advice (56:52) Enhancing Sleep Quality with Hypnosis: 1:01:34 Exploring Psychedelics in Trauma Therapy: 1:06:29 Integrating Hypnosis in Psychiatric Treatments: 1:10:37 Evolving Perception of Hypnosis in Medical Community: 1:16:25 Hypnosis and Meditation: Key Differences and Benefits: 1:17:38 Hypnosis vs. Opioids: Safety and Efficacy Compared: 1:19:27 Conclusion: The Future of Hypnosis: 1:24:55 Connect with Professor David Spiegel through the Reveri platforms on Instagram, Twitter/X, and LinkedIn. Learn more about Reveri and download the app at https://www.reveri.com/. Sponsors: If you want to improve your health, you need to measure where you're currently at. InsideTracker analyses up to 48 blood biomarkers including ApoB, LDL, HDL, A1C, and more before giving you advice to optimise your health. Get a 20% discount on your first order at insidetracker.com/simon. Eimele Essential 8 is a comprehensive multivitamin that is scientifically formulated to complement your plant-rich diet, increase and sustain your energy, support the immune system, as well as heart and brain health. Head to Eimele.com and use code SIMON at checkout for 10% off your first order. Whoop, the most advanced fitness and health wearable available. Your personalised fitness and health coach to recover faster, sleep better, and train smarter. Claim your first month free on join.whoop.com/simon. Simon Hill, MSc, BSc (Hons) Creator of theproof.com and host of The Proof with Simon Hill Author of The Proof is in the Plants Watch the episodes on YouTube or listen on Apple/Spotify Connect with me on Instagram, Twitter, and Facebook Nourish your gut with my Plant-Based Ferments Guide Download my complimentary Two-Week Meal Plan and high protein Plant Performance recipe book